CYP2E1 and gastric cancer: However, a subgroup analysis of the smoking population showed that CYP2E1 PstI/RsaI c2 carriers demonstrated an increased risk of gastric cancers (OR, 1.56; 95% CI, 1.14–2.15) compared with c1c1 carriers.